Desmopressin Acetate
NDC 39822-6250, desmopressin acetate, injection, solution, from XGen Pharmaceuticals DJB, Inc..
- Product NDC
- 39822-6250
- Status
- Listed
- Labeler
- XGen Pharmaceuticals DJB, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210223
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/39822-6250 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DESMOPRESSIN ACETATE4 ug/mL
Pharmacologic classes
Factor VIII Activator [EPC]; Increased Coagulation Factor VIII Activity [PE]; Increased Coagulation Factor VIII Concentration [PE]; Vasopressin Analog [EPC]; Vasopressins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 39822-6250-1 | 39822625001 | 1 VIAL in 1 CARTON (39822-6250-1) / 10 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1052a869-b64d-655d-e063-6294a90ad0e2Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=39822-6250NADAC price for package 39822625001
GET /v1/drugs/nadac/39822625001
Use it
Look up 39822-6250 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/39822-6250 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 39822-6250. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.